Top Stories

Flooded London hospitals ask patients to stay away

Two east London hospitals have asked patients to stay away after their emergency departments were hit by flooding on Sunday. Whipps Cross is without power and evacuating 100 inpatients and Newham hospital is asking patients to use other A&Es for urgent care. Ambulances are being redirected after torrential rain caused severe flooding in homes, roads […]

Top Stories

The new surgical tool inspired by a wasp

Scientists in the Netherlands have mimicked the way parasitoid wasps lay eggs to design a new tool for keyhole surgery. Currently tools used in these procedures are prone to clogging because they use suction. The new device avoids this by using friction. The team, at Delft University of Technology, have a working prototype and hope […]

Top Stories

The inconvenient truth of convenience

Convenience is the currency of the modern world—be it in entertainment, business and, yes, healthcare. Many of healthcare’s best innovations to date are born with convenience in mind. From faster, more accurate diagnostic tools, simpler lab work, and administrative streamlining, to telehealth and virtual appointments, patients have reaped significant benefits when inventors, researchers, and providers […]

Top Stories

Would Illumina’s acquisition of GRAIL constrict the expansion of the liquid biopsy space?

Earlier this year, the Federal Trade Commission’s (FTC) posed a roadblock in the path of sequencing giant Illumina’s $7.1 billion proposed acquisition of Grail, a healthcare company focusing on early cancer detection, and importantly, a 2016 spin-out from the former. Right now, the European Commission (EC) is also investigating the soundness of this deal. The […]

Top Stories

What insurers’ premium rate filings can tell us about predicted health utilization in 2022

Payers are expecting healthcare utilization to return to pre-pandemic levels, and as a result, are not factoring in additional costs or savings into their 2022 premiums, according to a report by the Kaiser Family Foundation. For the report, authors reviewed the initial 2022 premium rate filings for insurers participating in the Affordable Care Act exchanges’ […]

Top Stories

Eye problems in more patients spells end of Adverum’s DME gene therapy program

Adverum Biotechnologies disclosed in late April that a patient treated with its experimental gene therapy for diabetic macular edema (DME) experienced an unexpected drop in eye pressure, inflammation, and vision loss. That patient has been treated and is improving, though monitoring of the remaining patients has revealed similar problems in four others—two of which required […]